- Did you mean
- rna, virus
Search results - 11 results
Connaissez-vous le virus de l'encéphalite à tiques?36937
Publication Type: Non-peer reviewed scientific publication Authors: Vanessa Suin; Bernard Brochier Source: Médisphère, Volume 451 (2014) Keywords: de LE VIRUS Abstract: NA Service: Virale ziekten ...
Pourquoi encore se préoccuper de la rage?36936
Publication Type: Non-peer reviewed scientific publication Authors: Bernard Brochier Source: Medisphère, Volume 05/2014 (2014) Keywords: de rage Abstract: NA Service: Virale ziekten Viral diseases ...
Chapter Twenty Seven- Generation of immune globulin single variable domains by display technologies36931
fusion of different VHH to create multivalent VHH. These VHH can target one or several different epitopes, thereby increasing the chance of neutralization of different strains of virus Service: Virale ...
La rage des chauves-souris, petit rappel bien nécessaire avant la saison estival33960
x Service: Virale ziekten Viral diseases Maladies virales Category: A4 ...
Hepatitis E: een opkomende ziekte in België36871
Service: Virale ziekten Viral diseases Maladies virales Category: A4 ...
Two cases of imported canine rabies in the Brussels area within six months time36806
Abstract: na Service: Virale ziekten Viral diseases Maladies virales Category: A4 ...
Speuren naar rabies in the skye
Abstract: Not available Service: Virale ziekten Viral diseases Maladies virales Category: A4 ...
La rage des chiroptères
chiroptères de rage Abstract: na Service: Virale ziekten Viral diseases Maladies virales Category: A4 ...
Biosafety risk assessment of the Severe Acute Respiratory Syndrome (SARS) coronavirus and containment measures for the diagnostic and research laboratories
Health Organization Abstract: At the end of 2002, an outbreak of a new viral respiratory illness, called SARS (Severe Acute Respiratory Syndrome virus) occurred in China. The disease spread over Asia, ...
GMO Regulatory Aspects of Novel Investigational Vaccine Candidates
state-of-play in Belgium, this chapter discusses examples of regulatory journeys of applications with genetically modified viral vectors and novel vaccine candidates that have been reviewed by GMO national ...